Vicente Anido, Jr.
2017
In 2017, Vicente Anido, Jr. earned a total compensation of $10.1M as Chief Executive Officer and Chairman of the Board at Aerie Pharmaceuticals, a 226% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $618,410 |
|---|---|
| Option Awards | $4,964,033 |
| Salary | $710,000 |
| Stock Awards | $3,764,667 |
| Total | $10,057,110 |
Anido received $5M in option awards, accounting for 49% of the total pay in 2017.
Anido also received $618.4K in non-equity incentive plan, $710K in salary and $3.8M in stock awards.
Rankings
In 2017, Vicente Anido, Jr.'s compensation ranked 635th out of 14,666 executives tracked by ExecPay. In other words, Anido earned more than 95.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 635 out of 14,666 | 96th |
Division Manufacturing | 208 out of 5,772 | 96th |
Major group Chemicals And Allied Products | 50 out of 2,075 | 98th |
Industry group Drugs | 35 out of 1,731 | 98th |
Industry Biological Products, Except Diagnostic Substances | 4 out of 313 | 99th |
Source: SEC filing on April 27, 2018.
Anido's colleagues
We found three more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2017.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019